Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 medications have transformed weight management for millions of people seeking sustainable, medically-supervised treatment. These injectable therapies work by mimicking a natural hormone that controls appetite and blood sugar, helping patients achieve meaningful weight loss without extreme diet restriction. Understanding how GLP-1 injections function can help you decide if this treatment approach aligns with your health objectives.
How GLP-1 Receptor Agonist Injections Work
GLP-1 stands for glucagon-like peptide-1, a hormone your digestive system naturally produces when you eat. This hormone signals your brain that you are full, slows stomach emptying, and helps regulate blood sugar levels. Injectable GLP-1 medications amplify these signals, creating stronger satiety signals that reduce hunger and food cravings throughout the day.
When you inject a GLP-1 agonist like semaglutide, the medication binds to GLP-1 receptors located in your brain, pancreas, and gastrointestinal tract. This dual action simultaneously decreases appetite, improves portion control, and enhances how your body processes glucose. Most patients report feeling satisfied with smaller meals and experiencing fewer urges to eat between meals.
Clinical Evidence Behind GLP-1 Medication Results
Large-scale clinical trials have demonstrated that GLP-1 agonists produce significant, sustained weight loss in patients with obesity. The STEP trial program showed participants achieved average weight reductions of 15-22% of their body weight over 68 weeks, with many maintaining these results long-term. Beyond weight loss, patients experienced improvements in blood pressure, cholesterol levels, and metabolic markers associated with cardiovascular risk.
Medical organizations including the American Heart Association and the Endocrine Society now recognize GLP-1 medications as first-line treatment for weight management in eligible patients. The consistency of results across diverse patient populations supports these medications as a foundation of modern metabolic therapy. Individual outcomes vary based on genetics, lifestyle adherence, and metabolic factors that PlexusDx helps identify through precision testing.
Semaglutide Injections vs. Other GLP-1 Options
Semaglutide injections represent the most extensively studied GLP-1 formulation, with decades of clinical data supporting safety and efficacy. PlexusDx offers compounded semaglutide injections starting at $149 per month, allowing patients to access this proven therapy without insurance requirements or membership fees. Injectable delivery provides faster absorption and more consistent medication levels compared to oral formulations, which many patients find beneficial for appetite control.
PlexusDx also provides oral semaglutide, tirzepatide injection, and dual-compound GLP-Squared options for patients with different preferences or treatment goals. Your medical provider will recommend the formulation most likely to succeed based on your health profile, injection comfort level, and treatment timeline. All medications come from licensed 503A compounding pharmacies that meet strict quality and sterility standards.
Personalized GLP-1 Treatment Through Genetic Testing
Not all patients respond identically to the same GLP-1 medication, and genetic factors play a significant role in treatment outcomes. PlexusDx offers the Precision Peptide Genetic Test, which identifies how your unique genetic variants influence GLP-1 pathway sensitivity and weight loss potential. This test examines key genes including GLP1R, GIPR, FTO, and MC4R that directly impact how effectively your body responds to these therapies.
Understanding your genetic predispositions allows PlexusDx providers to select the most suitable GLP-1 formulation and dosing strategy for your physiology from the start. Patients with specific genetic profiles may respond better to semaglutide, tirzepatide, or combination approaches—information that optimizes your chances of success. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, mapping 14 peptide pathways and 49 individual peptides.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly do GLP-1 injections start working for appetite suppression?
Most patients notice reduced hunger and improved satiety within 3-7 days of starting treatment, though full appetite suppression typically develops over 2-4 weeks as dosing gradually increases. PlexusDx providers customize your dosing schedule to balance quick results with minimal side effects.
What does clinical trial data show about GLP-1 weight loss outcomes?
The STEP clinical trials demonstrated that semaglutide-treated patients lost 15-22% of baseline body weight over 68 weeks, compared to 2-3% in placebo groups. Additional studies show 60-70% of GLP-1 users achieve clinically significant weight loss of at least 10% body weight.
How much does PlexusDx semaglutide injection treatment cost monthly?
PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers, with no insurance required, no membership fees, and HSA/FSA eligibility. Your dose may need to go up as treatment progresses, but your monthly price won't increase.
What side effects should I expect from GLP-1 injections?
Common early side effects include mild nausea, reduced appetite, and occasional digestive changes that typically resolve within 1-2 weeks as your body adjusts. Serious side effects are rare but may include pancreatitis symptoms or severe allergic reactions—reasons to report any concerning symptoms immediately to your provider.
How does the Precision Peptide Genetic Test personalize my GLP-1 treatment?
The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes that influence GLP-1 sensitivity and weight loss response patterns. PlexusDx maps 14 peptide pathways and 150+ genetic insights to predict which GLP-1 formulation (semaglutide, tirzepatide, or combination) your body will respond to most effectively.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will Insurance Pay for Compounded Semaglutide?
How Much Weight Will You Lose with Ozempic?